FASS logotyp
Receptbelagd

Peka på symbolerna och beteckningarna till vänster för en förklaring.

Kontakt

Sök apotek med läkemedlet i lager

Sök lagerstatus

Heparin LEO

LEO Pharma

Injektionsvätska, lösning 5000 IE/ml
(klar, färglös/svagt gulfärgad vätska)

Fysiologiskt antikoagulans

Aktiv substans:
ATC-kod: B01AB01
Läkemedel från LEO Pharma omfattas av Läkemedelsförsäkringen.
  • Vad är miljöinformation?

Miljöinformation

Miljöpåverkan

Heparin

Miljörisk: Användning av kolhydrater bedöms inte medföra någon miljöpåverkan.


Läs mer

Detaljerad miljöinformation

The active ingredient in Heparin LEO® is heparin sodium. Heparin sodium is a polysaccharide (carbohydrate) – see Enclosure 1.


According to the European Medicines Agency guideline on environmental risk assessments for pharmaceuticals, vitamins, electrolytes, amino acids, peptides, proteins, carbohydrates, lipids, vaccines and herbal medicinal products are exempted because they are unlikely to result in significant risk to the environment (EMA, 2006).


Therefore, no environmental information is required.


Enclosure 1 Physical and Chemical characteristics


Names

International Nonproprietary Name (INN): Heparin sodium


Chemical description: Heterogeneous mixture of variably sulphated polysaccharide chains composed of repeating units of D-glucosamine and either L-iduronic acid or D-glucoronic acid.


Chemical Abstracts Service (CAS) Number: 9041-08-1


Description:

Physical form: Heparin sodium is a white to creamy-white, amorphous powder, odorless, moderately hygroscopic substance (Kilde and Petersen, 2008).


Structural formula:

Pentasaccharide sequence of Heparin (Antithrombin Binding Site of Heparin):


Pentasaccharide sequence of Heparin (Antithrombin Binding Site of Heparin)

Molecular formula:

Not known


Relative Molecular Mass:

Mean molecular weight (Mn): 12000-15000 Da


Solubility: 

The solubility of heparin in water is approx. 25 w/v%. Soluble in saline solutions. Practically insoluble in alcohol, acetone, benzene, chloroform, ether (Kilde and Petersen, 2008).


pH:

pH of 1% aqueous solution: 5.5-7.5 (Kilde and Petersen, 2008).


Optical rotation: 

> 35° (Kilde and Petersen, 2008).


References

I. European Medicines Agency (EMA), 2006. Committee for Medicinal Products for Human Use (CHMP). Guideline on the Environmental Risk Assessment of Medicinal Products for Human Use. EMEA/CHMP/SWP/4447/00 corr 2. 1 June 2006.

II. Kilde HD, Petersen CF, 2008. LEO Pharma A/S. Heparin sodium – Elucidation of Structure and other Characteristics.